Bowen v. Novartis Pharmaceuticals Corporation
| Edward Bowen |
| Novartis Pharmaceuticals Corporation |
| 6:2023cv00874 |
| May 11, 2023 |
| US District Court for the Middle District of Florida |
| David A Baker |
| Roy B Dalton |
| Tort Product Liability |
| 28 U.S.C. ยง 1332 Diversity-Product Liability |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on June 27, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 20 NOTICE TO COUNSEL: Parties who have been permitted by the Court to appear telephonically at the August 30, 2023 Status Conference shall join the conference by dialing 1-888-684-8852 ten minutes before the hearing is scheduled to begin. Access Code: 5851307. Security Code: 083023. Associated Cases: 6:21-md-03006-RBD-DAB et al. (ALL) |
| Filing 19 NOTICE of hearing: Status Conference set for 8/30/2023 at 10:00 AM in Orlando Courtroom 4 A before Judge Roy B. Dalton, Jr. Associated Cases: 6:21-md-03006-RBD-DAB et al. (ALL) |
| Filing 18 PLAINTIFF'S Exhibit List (Evidentiary Hearing). Associated Cases: 6:21-md-03006-RBD-DAB et al.(ALL) |
| Filing 17 DEFENDANT'S Exhibit List (Evidentiary Hearing). Associated Cases: 6:21-md-03006-RBD-DAB et al.(ALL) |
| Filing 16 Minute Entry for In Person Proceedings held before Judge Roy B. Dalton, Jr.: Evidentiary Hearing (DAY TWO) held on 6/6/2023. Court Reporter: Amie First. Associated Cases: 6:21-md-03006-RBD-DAB et al.(ALL) |
| Filing 15 Minute Entry for In Person Proceedings held before Judge Roy B. Dalton, Jr.: Evidentiary Hearing (DAY ONE) held on 6/5/2023. Court Reporter: Amie First. Associated Cases: 6:21-md-03006-RBD-DAB et al.(ALL) |
| Filing 14 PROOF of service by Edward Bowen (Wichmann, Lawana) |
Filing 13
PRETRIAL ORDER NO. 10: The parties in tagalong cases transferred into this MDL after dispositive motions were filed are DIRECTED to file notices indicating whether they adopt the MDL-wide summary judgment briefing (Docs. 238, 257, 268) by Wednesday, May 31, 2023. By Wednesday, May 31, 2023, Plaintiffs are ORDERED TO SHOW CAUSE by written response why the Bayack case should not be dismissed. The proposed schedule for post-remand case-specific discovery in the Middle District of Florida member cases is now due Wednesday, May 31, 2023. The Motion to Modify the Evidentiary Hearing Schedule (Doc. 274) is DENIED. Signed by Judge Roy B. Dalton, Jr. on 5/17/2023. Associated Cases: 6:21-md-03006-RBD-DAB et al. (ALL)
|
| Filing 12 TRANSFER IN from the Maryland. Case assigned to District Judge Roy B. Dalton, Jr. and Magistrate Judge David A. Baker. New Case Number: 6:23-cv-874-RBD-DAB. (RPB) |
| Filing 11 Case transferred in from District of Maryland; Case Number 1:23-cv-00680. File received electronically |
|
Filing 10
CONDITIONAL TRANSFER ORDER. Signed by Judge Maryland Unassigned on 5/5/2023. (c/s 5/11/2023 bas, Deputy Clerk) [Transferred from mdd on 5/11/2023.]
|
| MULTIDISTRICT LITIGATION Member Case. Create association to 6:21-md-03006-RBD-DAB, lead case for MDL. (RPB) |
| Case transferred to District of USDC for the Middle District of Florida. Original file, certified copy of transfer order, and docket sheet sent. (c/s 5/11/2023 bas, Deputy Clerk) [Transferred from mdd on 5/11/2023.] |
| Filing 9 Correspondence re: New Proposed Scheduling Order (Attachments: #1 Proposed Scheduling Order)(vdcs, Chambers) [Transferred from mdd on 5/11/2023.] |
| Filing 8 PAPERLESS ORDER granting #7 Motion to Appear Pro Hac Vice on behalf of Andrew Reissaus. Directing attorney Andrew Reissaus to register for pro hac vice filing in the District of Maryland through PACER at https://pacer.uscourts.gov/ if attorney has not already done so. The Pro Hac Vice option must be selected when registering. Signed by Clerk on 4/6/2023. (mh4s, Deputy Clerk) [Transferred from mdd on 5/11/2023.] |
| Filing 7 MOTION to Appear Pro Hac Vice for Andrew L. Reissaus (Filing fee $100, receipt number AMDDC-10531271.) by Novartis Pharmaceuticals Corporation(Johnston, Robert) [Transferred from mdd on 5/11/2023.] |
| Filing 6 Correspondence re: Proposed Scheduling Order (Attachments: #1 Proposed Scheduling Order)(vdcs, Chambers) [Transferred from mdd on 5/11/2023.] |
| Filing 5 Local Rule 103.3 Disclosure Statement by Novartis Pharmaceuticals Corporation identifying Corporate Parent Novartis Finance Corporation, a New York corporation, Corporate Parent Novartis Corporation, a New York corporation, Corporate Parent Novartis Holding, AG, a Swiss company, Corporate Parent Novartis AG, a Swiss company, whose shares are publicly traded on the SIX Swiss Exchange, and whose American Depository Shares are publicly traded on the New York Stock Exchange, Other Affiliate Novartis AG for Novartis Pharmaceuticals Corporation.(Johnston, Robert) [Transferred from mdd on 5/11/2023.] |
| Filing 4 Defendant Novartis Pharmaceuticals Corporation's ANSWER to #1 Complaint by Novartis Pharmaceuticals Corporation.(Johnston, Robert) [Transferred from mdd on 5/11/2023.] |
| Filing 3 NOTICE of Appearance by Robert Eric Johnston on behalf of Novartis Pharmaceuticals Corporation (Johnston, Robert) [Transferred from mdd on 5/11/2023.] |
| Filing 2 Summons Issued 21 days as to Novartis Pharmaceuticals Corporation.(bas, Deputy Clerk) [Transferred from mdd on 5/11/2023.] |
| Filing 1 COMPLAINT against Novartis Pharmaceuticals Corporation ( Filing fee $ 402 receipt number AMDDC-10483734.), filed by Edward Bowen. (Attachments: #1 Civil Cover Sheet, #2 Summons)(Davani, Ali) [Transferred from mdd on 5/11/2023.] |
| Case Assigned to Chief Judge James K. Bredar. (kos, Deputy Clerk) [Transferred from mdd on 5/11/2023.] |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Florida Middle District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
| Search for this case: Bowen v. Novartis Pharmaceuticals Corporation | |
|---|---|
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Web | [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ] |
| Plaintiff: Edward Bowen | |
| Represented By: | Ali Reza Davani |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
| Defendant: Novartis Pharmaceuticals Corporation | |
| Represented By: | Robert E. Johnston |
| Represented By: | Andrew L. Reissaus |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
